UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 11-K
(Mark One)
ý | ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the fiscal year ended December 31, 2019
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
Commission file number 001-37702
THE RETIREMENT AND SAVINGS PLAN FOR
AMGEN MANUFACTURING, LIMITED
State Road 31, Kilometer 24.6, Juncos, Puerto Rico 00777
(Full title and address of the plan)
AMGEN INC.
(Name of issuer of the securities held)
One Amgen Center Drive, | 91320-1799 | |
Thousand Oaks, California | (Zip Code) | |
(Address of principal executive offices) | ||
The Retirement and Savings Plan for
Amgen Manufacturing, Limited
Audited Financial Statements
and Supplemental Schedule
Year Ended December 31, 2019
Contents
Audited Financial Statements: | |
Supplemental Schedule: | |
Report of Independent Registered Public Accounting Firm
To the Plan Participants and the Plan Administrator of The Retirement and Savings Plan for Amgen Manufacturing, Limited
Opinion on the Financial Statements
We have audited the accompanying statements of net assets available for benefits of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) as of December 31, 2019 and 2018, and the related statement of changes in net assets available for benefits for the year ended December 31, 2019, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2019 and 2018, and the changes in its net assets available for benefits for the year ended December 31, 2019, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Supplemental Schedule
The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2019, has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.
/s/ ERNST & YOUNG LLP
We have served as the Plan’s auditor since 1992.
Los Angeles, California
June 16, 2020
1
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Statements of Net Assets Available for Benefits
December 31, | ||||||||
2019 | 2018 | |||||||
Assets | ||||||||
Investments at fair value | $ | 527,261,698 | $ | 407,898,859 | ||||
Notes receivable from participants | 15,872,871 | 14,040,310 | ||||||
Other – principally due from broker | 494,029 | 470,827 | ||||||
Total assets | 543,628,598 | 422,409,996 | ||||||
Liabilities | ||||||||
Other – principally due to broker | 581,092 | 618,395 | ||||||
Total liabilities | 581,092 | 618,395 | ||||||
Net assets available for benefits | $ | 543,047,506 | $ | 421,791,601 | ||||
See accompanying notes.
2
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Statement of Changes in Net Assets Available for Benefits
Year Ended December 31, | ||||
2019 | ||||
Additions to (deductions from) net assets: | ||||
Employer contributions | $ | 15,576,832 | ||
Participant contributions | 15,230,624 | |||
Rollover contributions | 532,295 | |||
Interest and dividend income | 4,992,030 | |||
Net realized/unrealized gains | 95,270,354 | |||
Interest income on notes receivable from participants | 747,783 | |||
Benefits paid | (10,418,189 | ) | ||
Investment and administrative fees | (675,824 | ) | ||
Net increase | 121,255,905 | |||
Net assets available for benefits at beginning of year | 421,791,601 | |||
Net assets available for benefits at end of year | $ | 543,047,506 | ||
See accompanying notes.
3
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements
December 31, 2019
1. Description of the Plan
The following description of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
General
The Plan was established effective May 1, 1992, and was amended and restated effective January 1, 2017, and subsequently amended, with the most recent amendment adopted on December 12, 2019. The Plan is a defined contribution plan covering substantially all Puerto Rico resident employees of Amgen Manufacturing, Limited (the Company), a wholly owned subsidiary of Amgen Inc. (Amgen). The Plan is intended to qualify under Section 1081.01 of the Puerto Rico Internal Revenue Code of 2011, as amended (the PR Code) (see Note 4, Income Tax Status) and section 407(d)(3)(A) of the Employee Retirement Income Security Act of 1974 (ERISA).
Contributions
Subject to certain limitations (as defined in the Plan), participants may elect to contribute up to 30% of their eligible compensation in pre-tax contributions and after-tax contributions or a combination of these types of contributions. A participant’s pre-tax contributions are subject to PR Code and Plan limitations and could not exceed $15,000 in 2019. Participants may elect to contribute after-tax contributions beginning January 1 of the year following the year the participant was hired. Participant after-tax contributions are subject to PR Code and Plan limitations and could not exceed $1,500 in 2019. Unless an employee has voluntarily enrolled in the Plan or has declined to participate in the Plan within the first 30 days of employment, all newly eligible participants are automatically enrolled in the Plan, and contributions equal to 5% of their eligible compensation are withheld and contributed to the Plan as pre-tax contributions; such contributions are automatically increased by 1% per year until their contributions reach 10% of their eligible compensation. Participants may elect to adjust, cease or resume their contributions at any time.
Participants who are at least age 50 by the close of the Plan year may also elect to make certain additional pre-tax contributions, referred to as catch-up contributions, that are subject to PR Code and Plan limitations and could not exceed $1,500 in 2019. Participants may also contribute pre-tax and after-tax amounts representing distributions from certain other retirement plans qualified in Puerto Rico, referred to as rollover contributions (as defined in the Plan).
Each pay period, the Company makes a non-elective contribution for all eligible participants, whether or not they have elected to make contributions to the Plan, equal to 4% of each participant’s eligible compensation up to a maximum of $11,200 in 2019 (Core Contributions). In addition, the Company makes a contribution equal to amounts contributed by the participant as pre-tax contributions, including catch-up contributions, of up to 5% of eligible compensation (Matching Contributions). Matching Contributions could not exceed $14,000 in 2019.
Participants select the investments in which their contributions, including their Core Contributions and Matching Contributions (collectively, Company Contributions), are to be invested, electing among various alternatives, including Amgen common stock (Amgen stock). Participants may direct a maximum of 20% of contributions to be invested in Amgen stock. In addition, participants may transfer amounts among the investment options at any time, subject to certain limitations. Notwithstanding the foregoing, if 20% or more of the value of a participant’s Plan account is invested in Amgen stock, the Plan document provides that no transfers from other investment options can be made to invest in Amgen stock.
The accounts of participants who had never made an investment election are allocated to investments under a qualified default investment alternative, which is intended to be compliant with ERISA regulations. At any time, participants may elect to alter the investments in their accounts made under a qualified default investment alternative.
4
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
Vesting
Participants are immediately vested with respect to their contributions and Matching Contributions and earnings and losses (hereafter referred to as earnings) thereon. Participants hired prior to January 1, 2020, are also immediately vested with respect to their Core Contributions and earnings thereon. Participants hired on or after January 1, 2020, vest in full with respect to their Core Contributions and earnings thereon after three years of service, as defined by the terms of the Plan, or upon reaching age 65 while employed by the Company, if earlier. If a participant ceases to be an employee before fully vesting in their account, the non-vested portion of the participant’s account will be treated as a forfeiture, as defined by the terms of the Plan, on the earlier of (i) the date the participant incurs a five-year break in service, as defined by the terms of the Plan or, (ii) the date the participant receives a distribution of the entire vested portion of their account.
Participant Accounts
Each participant’s account is credited with: (a) the participant’s contributions; (b) an allocation of Company Contributions; and (c) earnings. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account.
Plan Investments
Participants can invest in any of 16 different asset classes as well as Amgen stock or may actively manage their account under a self-directed brokerage arrangement in which a wider array of investment options are available. The value of an investment in an asset class is determined by its underlying investment vehicles, which may include one or more of the following: mutual funds, collective trust funds and portfolios, which are separately managed exclusively for the benefit of Plan participants and their beneficiaries (separately managed portfolios). The separately managed portfolios are composed primarily of investments in publicly traded common and preferred stocks. The asset classes are designed to provide participants with choices among a variety of investment objectives.
Payments of Benefits
Subject to Plan limitations, upon termination of employment, including termination due to disability (as defined in the Plan) or retirement, a participant may elect to receive a full or partial distribution of his or her account balance in: (a) a single payment in cash; (b) a single distribution in full shares of Amgen stock (with any fractional shares paid in cash); (c) a single distribution paid in a combination of cash and full shares of Amgen stock; or (d) a rollover distribution to an eligible retirement plan.
Participants may also elect to maintain their account balance in the Plan subsequent to termination of employment, provided that their account balance is greater than $1,000.
If a participant dies before receiving the value of his or her account balance, the participant’s beneficiary may elect to receive the distribution of remaining funds from among the alternatives described above, subject to certain Plan limitations.
Certain restrictions apply to withdrawals from the Plan while a participant continues to be employed by the Company.
Notes Receivable from Participants
Subject to certain restrictions, a participant can have up to two loans outstanding at any one time from his or her Plan account with a combined maximum loan amount that may not exceed the lesser of: (a) 50% of the participant’s account balance or (b) $50,000 less certain adjustments, as applicable (as defined in the Plan). A participant’s loan is secured by his or her Plan account balance. Loans made prior to January 1, 2006, bear interest at fixed rates based on the average borrowing rates of certain major banks. Loans made on or after January 1, 2006, bear interest at fixed rates which, until changed by the Company, are based on the prime rate plus one percentage point as published in The Wall Street Journal, determined as of the last day of the calendar quarter preceding origination or such other rate as may be required by law. Loans are generally payable in installments over periods ranging from one to five years, unless the loan is used to acquire a principal residence for which the term of the loan may be up to 20 years. Principal and interest payments are allocated to the participant’s account.
Plan Termination
Although it has not expressed any intent to do so, the Company has the right under the Plan to terminate the Plan subject to the provisions of ERISA. Upon termination, participants would receive distributions of their account balances.
5
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
Trustee and Custodians
Banco Popular de Puerto Rico is the Plan’s trustee. Bank of America, N.A.is the Plan’s trustee with respect to self-directed brokerage arrangement and the Amgen common stock fund. Merrill Lynch, Pierce, Fenner and Smith, Inc.is the Plan’s custodian with respect to the self-directed brokerage arrangement and the Amgen Common Stock fund. Northern Trust Company, NA (Northern) is the Plan’s custodian with respect to the asset classes.
2. Summary of Significant Accounting Policies
Basis of Accounting
The accompanying financial statements are prepared on the accrual basis of accounting.
Fair Value Measurement
The investments of the Plan are reported at fair value. Fair value is generally defined as the price that would be received to sell an asset or paid to transfer a liability (the exit price) in an orderly transaction between market participants at the measurement date (see Note 3, Fair Value Measurements).
Investment Income and Losses
Dividend income is recognized on the ex-dividend date, and interest income is recorded on an accrual basis. Unrealized gains and losses on investments are measured by the change in the difference between the fair value and cost of the securities held at the beginning of the year (or date purchased if acquired during the Plan year) and the end of the year. Realized gains and losses from security transactions are recorded based on the weighted-average cost of securities sold.
Notes Receivable from Participants
Notes receivable from participants are carried at their unpaid balance plus accrued but unpaid interest, as applicable.
Due from/to Brokers
Purchases and sales of investments are recorded on a trade-date basis. Amounts due from and due to brokers arise from unsettled sale and purchase transactions, respectively.
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Recently issued accounting pronouncement
In July 2018, the Financial Accounting Standards Board issued a new accounting standard that amended the fair value hierarchy disclosure to indicate that certain types of investments, including collective trust funds, should not always be considered to be eligible to use the net asset value per unit as a practical expedient. Furthermore, this standard clarifies that an evaluation should be made of whether a readily determinable fair value exists for such investments or whether the investments qualify for measurement at the practical expedient. The Plan prospectively adopted this standard on January 1, 2019, which resulted in discontinuing the use of the practical expedient for determining the fair values of the Plan’s investments in collective trust funds. Accordingly, the aggregate fair value of such investments was moved from its location as a reconciling item of the fair value hierarchy table to a line item within this table with an assigned fair value measurement level. See Note 3, Fair Value Measurements.
6
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
3. Fair Value Measurements
The Plan uses various valuation approaches in determining the fair value of investments within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the investment based on market data obtained from independent sources. Unobservable inputs are inputs that reflect assumptions about the inputs that market participants would use in pricing the investment and are developed based on the best information available in the circumstances. The fair value hierarchy is divided into three levels based on the source of inputs as follows:
Level 1 – Valuations based on unadjusted quoted prices in active markets for identical investments that the Plan has the ability to access;
Level 2 – Valuations for which all significant inputs are observable, either directly or indirectly, other than Level 1 inputs;
Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The availability of observable inputs can vary among the various types of investments. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used for measuring fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level of input used that is significant to the overall fair value measurement.
The following fair value hierarchy tables present information about each major class/category of the Plan’s investments measured at fair value:
Fair value measurements at December 31, 2019, using | ||||||||||||||||
Quoted prices in active markets for identical assets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Total | |||||||||||||
Amgen stock | $ | 103,512,169 | $ | — | $ | — | $ | 103,512,169 | ||||||||
Cash and cash equivalents | 1,116,538 | — | — | 1,116,538 | ||||||||||||
Collective trust funds | — | 305,516,006 | — | 305,516,006 | ||||||||||||
Common and preferred stock | 91,588,716 | 329,692 | — | 91,918,408 | ||||||||||||
Mutual funds | 22,607,250 | — | — | 22,607,250 | ||||||||||||
Self-directed brokerage accounts | 2,591,327 | — | — | 2,591,327 | ||||||||||||
$ | 221,416,000 | $ | 305,845,698 | $ | — | $ | 527,261,698 | |||||||||
7
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
Fair value measurements at December 31, 2018, using | ||||||||||||||||
Quoted prices in active markets for identical assets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Total | |||||||||||||
Amgen stock | $ | 83,047,933 | $ | — | $ | — | $ | 83,047,933 | ||||||||
Common and preferred stocks | 68,895,253 | — | — | 68,895,253 | ||||||||||||
Mutual funds | 36,118,321 | — | — | 36,118,321 | ||||||||||||
Self-directed brokerage accounts | 2,145,935 | — | — | 2,145,935 | ||||||||||||
Other | 722 | — | — | 722 | ||||||||||||
$ | 190,208,164 | $ | — | $ | — | $ | 190,208,164 | |||||||||
Collective trust funds measured at net asset value | 217,690,695 | |||||||||||||||
Total investments measured at fair value | $ | 407,898,859 | ||||||||||||||
The fair values of substantially all common stocks (including Amgen stock), preferred stocks, mutual funds and underlying investments of self-directed brokerage accounts are valued using quoted market prices in active markets with no valuation adjustment.
Collective trust funds represent interests in pooled investment vehicles designed typically for collective investment of employee benefit trusts. The fair values of these investments are determined by reference to the net asset value per unit provided by the fund managers as the basis for current transactions. The only redemption restriction with respect to these investments is on the Wells Fargo Stable Value Fund W (fair value of $36,097,165 and $29,528,317 as of December 31, 2019 and 2018, respectively), which requires a one-year notice to be given in the event of complete liquidation.
4. Income Tax Status
The Plan received an opinion letter from the Puerto Rico Treasury Department (PRTD) dated February 26, 2018, with an effective date of January 1, 2017, stating that the Plan meets the requirements of Section 1081.01 of the PR Code and the regulations thereunder, and, therefore the related trust forming part of the Plan is exempt from taxation. Subsequently, three amendments were made to the Plan, and the Plan received a letter from the PRTD dated October 30, 2018 and August 8, 2019, stating the PRTD has no objection to these amendments. Subsequent to these letters, the Plan was amended again. Once qualified, the Plan is required to operate in conformity with the PR Code to maintain its qualification.
For taxable year 2019, the Company believes the Plan satisfied, and operated in compliance with, the applicable requirements of the PR Code and therefore believes that the Plan, as amended, is qualified and the related trust is tax exempt.
5. Party-in-Interest Transactions
Parties-in-Interest are certain entities defined under Department of Labor regulations, including Amgen, and other parties that provide services to the Plan, such as the trustees, custodians and investment managers. The Plan pays the custodians certain administrative and investment management fees, and the Company pays certain administrative fees on behalf of the Plan. The Plan makes investments in collective trust funds managed by Northern, certain of the Plan’s investment managers and other third parties and may invest in securities of entities that are parties-in-interest. The Plan also invests in shares of common stock of Amgen and receives dividends on those shares. Notes receivable from participants are also considered party-in-interest transactions.
8
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
6. Reconciliation of Financial Statements to Form 5500
The reconciliation of net assets available for benefits per the financial statements to the Form 5500 consisted of the following:
December 31, | ||||||||
2019 | 2018 | |||||||
Net assets available for benefits per the financial statements | $ | 543,047,506 | $ | 421,791,601 | ||||
Amounts allocated to withdrawing participants | (24,938 | ) | — | |||||
Deemed loans | (485,301 | ) | (481,033 | ) | ||||
Net assets per the Form 5500 | $ | 542,537,267 | $ | 421,310,568 | ||||
The following is a reconciliation of distributions per the financial statements to the Form 5500:
Year Ended December 31, 2019 | ||||
Benefits paid | $ | (10,418,189 | ) | |
Investment and administrative fees | (675,824 | ) | ||
Total distributions per the financial statements | (11,094,013 | ) | ||
Amounts allocated to withdrawing participants at December 31, 2019 | (24,938 | ) | ||
Deemed loans at December 31, 2018 | 481,033 | |||
Deemed loans at December 31, 2019 | (485,301 | ) | ||
Total distributions per the Form 5500 | $ | (11,123,219 | ) | |
9
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Supplemental Schedule
The Retirement and Savings Plan for Amgen Manufacturing, Limited
EIN: 98-0210484 Plan: #001
As of December 31, 2019
Schedule H, line 4i – Schedule of Assets (Held at End of Year)
Identity of Issue | Description of Investment | Current Value | ||||||||
Amgen Stock* | Employer Securities 429,387 shares | $ | 103,512,169 | |||||||
$ | 103,512,169 | |||||||||
Capital Preservation Asset Class: | ||||||||||
Wells Fargo Stable Value Fund W* | Collective Trust Fund 630,818 units | 36,097,165 | ||||||||
NT Collective Short Term Investment Fund* | Collective Trust Fund 2,824,684 units | 2,824,684 | ||||||||
Total Capital Preservation Asset Class | 38,921,849 | |||||||||
Emerging Markets Equity Asset Class: | ||||||||||
J.P. Morgan Emerging Markets Equity Focus Fund* | Collective Trust Fund 164,907 units | 4,340,358 | ||||||||
Blackrock FTSE RAFI Emerging Index Non Lendable Fund F* | Collective Trust Fund 291,747 units | 4,148,291 | ||||||||
NT Collective Emerging Markets Fund / Non Lending* | Collective Trust Fund 2,887 units | 563,583 | ||||||||
Total Emerging Markets Equity Asset Class | 9,052,232 | |||||||||
Fixed Income Asset Class: | ||||||||||
Metlife Core Plus Collective Fund* | Collective Trust Fund 1,066,560 units | 10,697,593 | ||||||||
Wellington Core Bond Plus Portfolio Collective Investment Trust II* | Collective Trust Fund 838,989 units | 10,697,109 | ||||||||
Northern Trust Global Investments Collective Daily Aggregate Bond Index Fund Non Lending* | Collective Trust Fund 27,252 units | 4,161,927 | ||||||||
Putnam Absolute Return Fixed Income Fund* | Collective Trust Fund 40,209 units | 3,065,549 | ||||||||
Schroder Global Strategic Bond Trust Class W* | Collective Trust Fund 300,821 units | 3,065,362 | ||||||||
Interest Bearing Cash | Cash and Cash Equivalents 44 units | 44 | ||||||||
Total Fixed Income Asset Class | 31,687,584 | |||||||||
Fixed Income Index Asset Class: | ||||||||||
NT Collective Aggregate Bond Index Fund / Non Lending* | Collective Trust Fund 71,005 units | 10,843,819 | ||||||||
Total Fixed Income Index Asset Class | 10,843,819 | |||||||||
High Yield Asset Class: | ||||||||||
Mackay Shields High Yield Bond CIT (Fund Code-2196)* | Collective Trust Fund 486,865 units | 5,754,749 | ||||||||
Blackrock Funds V High Yield Bond Portfolio Class K | Mutual Fund 738,118 units | 5,742,560 | ||||||||
Total High Yield Asset Class | 11,497,309 | |||||||||
Inflation Protection Asset Class: | ||||||||||
NT Collective Treasury Inflation/Protected Securities Index Fund / Non Lending* | Collective Trust Fund 58,147 units | 8,809,917 | ||||||||
Total Inflation Protection Asset Class | 8,809,917 | |||||||||
10
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
International Growth Asset Class: | ||||||||||
Artisan International Fund* | Collective Trust Fund 260,307 units | 7,168,846 | ||||||||
Reliance Trust Instituitional Retirement Trust GQG Partners International Equity Fund Series 11 Class C* | Collective Trust Fund 662,794 units | 7,045,499 | ||||||||
NT Collective EAFE Index Fund / Non Lending* | Collective Trust Fund 2,163 units | 1,778,350 | ||||||||
Interest Bearing Cash | Cash and Cash Equivalents 31 units | 31 | ||||||||
Total International Growth Asset Class | 15,992,726 | |||||||||
International Index Asset Class: | ||||||||||
NT Collective All Country World Index (ACWI) Ex/US Fund / Non Lending* | Collective Trust Fund 134,757 units | 22,472,134 | ||||||||
Total International Index Asset Class | 22,472,134 | |||||||||
International Value Asset Class: | ||||||||||
Altrinsic International Equity Fund Class C* | Collective Trust Fund 390,069 units | 5,141,183 | ||||||||
Dodge & Cox International Fund | Mutual Fund 116,612 units | 5,084,285 | ||||||||
NT Collective EAFE Index Fund / Non Lending* | Collective Trust Fund 2,163 units | 746,455 | ||||||||
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending* | Collective Trust Fund 1,033 units | 1,033 | ||||||||
Total International Value Asset Class | 10,972,956 | |||||||||
Large Cap Growth Asset Class: | ||||||||||
Northern Trust Global Investments Collective Daily Russell 1000 Growth Index Fund - Non Lending* | Collective Trust Fund 4,460 units | 2,467,109 | ||||||||
Visa Inc. Class A | Common and Preferred Stock 13,071 shares | 2,456,041 | ||||||||
Amazon Inc. | Common and Preferred Stock 1,272 shares | 2,350,452 | ||||||||
Salesforce.com Inc. | Common and Preferred Stock 7,042 shares | 1,843,524 | ||||||||
Microsoft Corporation | Common and Preferred Stock 11,603 shares | 1,829,793 | ||||||||
Intuit Inc. | Common and Preferred Stock 3,235 shares | 1,591,225 | ||||||||
Facebook Inc. | Common and Preferred Stock 6,843 shares | 1,404,526 | ||||||||
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending* | Collective Trust Fund 1,299,539 units | 1,299,539 | ||||||||
ServiceNow Inc. | Common and Preferred Stock 4,237 shares | 1,196,190 | ||||||||
UnitedHealth Group Inc. | Common and Preferred Stock 4,055 shares | 1,192,089 | ||||||||
Yum! Brands Inc. | Common and Preferred Stock 11,204 shares | 1,128,579 | ||||||||
Illumina, Inc. | Common and Preferred Stock 1,658 shares | 1,065,881 | ||||||||
Paypal Holdings Inc. | Common and Preferred Stock 9,347 shares | 1,011,065 | ||||||||
Autodesk Inc. | Common and Preferred Stock 5,451 shares | 1,000,040 | ||||||||
Abbott Laboratories | Common and Preferred Stock 11,303 shares | 981,779 | ||||||||
Alphabet Inc. Class C | Common and Preferred Stock 731 shares | 977,362 | ||||||||
Nike Inc. Class B | Common and Preferred Stock 9,537 shares | 966,193 | ||||||||
Mondelez International Inc. | Common and Preferred Stock 17,287 shares | 952,168 | ||||||||
Adobe Systems Inc. | Common and Preferred Stock 2,827 shares | 932,373 | ||||||||
11
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Workday Inc. Class A | Common and Preferred Stock 3,758 shares | 867,967 | ||||||||
Match Group Inc. | Common and Preferred Stock 10,437 shares | 856,982 | ||||||||
Equinix Inc. | Common and Preferred Stock 1,460 shares | 852,202 | ||||||||
Alphabet Inc. Class A | Common and Preferred Stock 625 shares | 837,119 | ||||||||
TJX Companies Inc. | Common and Preferred Stock 12,930 shares | 789,506 | ||||||||
Ecolab, Inc. | Common and Preferred Stock 4,000 shares | 771,960 | ||||||||
Becton, Dickinson and Company | Common and Preferred Stock 2,799 shares | 761,244 | ||||||||
Netflix, Inc. | Common and Preferred Stock 2,297 shares | 743,240 | ||||||||
Danaher Corporation | Common and Preferred Stock 4,835 shares | 742,076 | ||||||||
Booking Holdings Inc. | Common and Preferred Stock 349 shares | 716,752 | ||||||||
FleetCor Technologies Inc. | Common and Preferred Stock 2,449 shares | 704,627 | ||||||||
Alibaba Group Holding Limited | Common and Preferred Stock 3,279 shares | 695,476 | ||||||||
Costar Group Inc. | Common and Preferred Stock 1,147 shares | 686,250 | ||||||||
Automatic Data Processing, Inc. | Common and Preferred Stock 3,604 shares | 614,482 | ||||||||
Regeneron Pharmaceuticals, Inc. | Common and Preferred Stock 1,599 shares | 600,393 | ||||||||
Edwards Lifesciences Corporation | Common and Preferred Stock 2,511 shares | 585,791 | ||||||||
Zoetis Inc. Class A | Common and Preferred Stock 4,256 shares | 563,282 | ||||||||
IHS Markit Limited | Common and Preferred Stock 7,015 shares | 528,580 | ||||||||
Linde PLC | Common and Preferred Stock 2,436 shares | 518,624 | ||||||||
Ulta Salon Cosmetics & Fragrance Inc. | Common and Preferred Stock 2,035 shares | 515,140 | ||||||||
Novo Nordisk A/S | Common and Preferred Stock 8,682 shares | 502,514 | ||||||||
Estee Lauder Companies Inc. Class A | Common and Preferred Stock 2,148 shares | 443,648 | ||||||||
Texas Instruments Inc. | Common and Preferred Stock 3,059 shares | 392,439 | ||||||||
Monster Beverage Corp | Common and Preferred Stock 6,011 shares | 381,999 | ||||||||
Align Technology Inc. | Common and Preferred Stock 1,291 shares | 360,241 | ||||||||
Floor & Decor Holdings Inc. | Common and Preferred Stock 6,675 shares | 339,157 | ||||||||
Activision Blizzard Inc. | Common and Preferred Stock 4,372 shares | 259,784 | ||||||||
Sarepta Therapeutics Inc. | Common and Preferred Stock 1,926 shares | 248,531 | ||||||||
Mirati Therapeutics Inc. | Common and Preferred Stock 1,567 shares | 201,924 | ||||||||
Atlassian Corporation PLC Class A | Common and Preferred Stock 1,565 shares | 188,332 | ||||||||
Twilio Inc. Class A | Common and Preferred Stock 1,645 shares | 161,671 | ||||||||
Abiomed Inc. | Common and Preferred Stock 843 shares | 143,807 | ||||||||
Sea Limited | Common and Preferred Stock 2,185 shares | 87,881 | ||||||||
Total Large Cap Growth Asset Class: | 44,309,549 | |||||||||
Large Cap Index Asset Class: | ||||||||||
NT Collective S&P 500 Index Fund – Non Lending* | Collective Trust Fund 9,934 units | 114,337,374 | ||||||||
Total Large Cap Index Asset Class | 114,337,374 | |||||||||
Large Cap Value Asset Class: | ||||||||||
Northern Trust Collective Russell 1000 Value Index Fund - Non Lending* | Collective Trust Fund 1,978 units | 829,341 | ||||||||
Alphabet Inc. | Common and Preferred Stock 471 shares | 629,736 | ||||||||
Microsoft Corporation | Common and Preferred Stock 3,432 shares | 541,226 | ||||||||
National Oilwell Varco, Inc. | Common and Preferred Stock 19,500 shares | 490,730 | ||||||||
Skyworks Solutions Inc | Common and Preferred Stock 3,927 shares | 474,696 | ||||||||
12
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Qorvo, Inc. | Common and Preferred Stock 4,075 shares | 473,637 | ||||||||
Airbus SE | Common and Preferred Stock 3,007 shares | 440,417 | ||||||||
CVS Health Corporation | Common and Preferred Stock 5,619 shares | 417,436 | ||||||||
KKR & Company Inc. Class A | Common and Preferred Stock 13,444 shares | 392,161 | ||||||||
Anthem Inc. | Common and Preferred Stock 1,289 shares | 389,317 | ||||||||
Amazon Inc. | Common and Preferred Stock 179 shares | 330,763 | ||||||||
Facebook Inc. Class A | Common and Preferred Stock 1,588 shares | 325,937 | ||||||||
Booking Holdings Inc. | Common and Preferred Stock 157 shares | 322,436 | ||||||||
Mastercard Inc. Class A | Common and Preferred Stock 1,062 shares | 317,103 | ||||||||
Swiss Re AG | Common and Preferred Stock 2,820 shares | 316,553 | ||||||||
Hilton Worldwide Holdings Inc. | Common and Preferred Stock 2,840 shares | 314,984 | ||||||||
Marriott International Inc. Class A | Common and Preferred Stock 1,990 shares | 301,346 | ||||||||
Interest Bearing Cash | Cash and Cash Equivalents 297,189 units | 297,189 | ||||||||
Wells Fargo & Company* | Common and Preferred Stock 5,400 shares | 290,520 | ||||||||
The Charles Schwab Corporation | Common and Preferred Stock 6,050 shares | 287,738 | ||||||||
Nvidia Corporation | Common and Preferred Stock 1,220 shares | 287,066 | ||||||||
Visa Inc. Class A | Common and Preferred Stock 1,514 shares | 284,481 | ||||||||
Capital One Financial Corporation | Common and Preferred Stock 2,550 shares | 262,421 | ||||||||
Bank of America Corporation* | Common and Preferred Stock 7,000 shares | 246,540 | ||||||||
McKesson Corporation | Common and Preferred Stock 1,764 shares | 243,996 | ||||||||
Charter Communications, Inc. Class A | Common and Preferred Stock 500 shares | 242,540 | ||||||||
FedEx Corporation | Common and Preferred Stock 1,600 shares | 241,936 | ||||||||
Comcast Corporation Class A | Common and Preferred Stock 5,100 shares | 229,347 | ||||||||
Cigna Corporation | Common and Preferred Stock 1,101 shares | 225,143 | ||||||||
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending* | Collective Trust Fund 212,180 units | 212,180 | ||||||||
Occidental Petroleum Corporation | Common and Preferred Stock 5,100 shares | 210,171 | ||||||||
AmerisourceBergen Corp. | Common and Preferred Stock 2,447 shares | 208,044 | ||||||||
Bristol-Myers Squibb Company | Common and Preferred Stock 3,200 shares | 205,408 | ||||||||
Sanofi-Aventis | Common and Preferred Stock 4,050 shares | 203,310 | ||||||||
Everest Re Group Ltd | Common and Preferred Stock 732 shares | 202,647 | ||||||||
Oracle Corporation | Common and Preferred Stock 3,747 shares | 198,516 | ||||||||
United Parcel Service Inc. Class B | Common and Preferred Stock 1,528 shares | 178,868 | ||||||||
UnitedHealth Group Inc. | Common and Preferred Stock 575 shares | 169,039 | ||||||||
Brookfield Asset Management Inc. Voting Shares Class A | Common and Preferred Stock 2,914 shares | 168,429 | ||||||||
Roche Holdings Limited | Common and Preferred Stock 4,100 shares | 166,706 | ||||||||
The Goldman Sachs Group Inc. | Common and Preferred Stock 725 shares | 166,699 | ||||||||
United Technologies Corporation | Common and Preferred Stock 1,100 shares | 164,736 | ||||||||
Microchip Technology Inc. | Common and Preferred Stock 1,550 shares | 162,316 | ||||||||
Novartis AG | Common and Preferred Stock 1,700 shares | 160,973 | ||||||||
S&P Global Inc. | Common and Preferred Stock 583 shares | 159,188 | ||||||||
MetLife Inc.* | Common and Preferred Stock 3,100 shares | 158,007 | ||||||||
HP Inc. | Common and Preferred Stock 7,600 shares | 156,180 | ||||||||
Johnson Controls International PLC | Common and Preferred Stock 3,793 shares | 154,413 | ||||||||
Bank of New York Mellon Corporation | Common and Preferred Stock 3,000 shares | 150,990 | ||||||||
Glaxosmithkline PLC | Common and Preferred Stock 3,150 shares | 148,019 | ||||||||
13
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
JP Morgan Chase & Company* | Common and Preferred Stock 950 shares | 132,430 | ||||||||
AstraZeneca PLC | Common and Preferred Stock 2,600 shares | 129,636 | ||||||||
Hewlett Packard Enterprise Company | Common and Preferred Stock 7,600 shares | 120,536 | ||||||||
TE Connectivity Limited | Common and Preferred Stock 1,250 shares | 119,800 | ||||||||
Baker Hughes | Common and Preferred Stock 4,600 shares | 117,898 | ||||||||
American Express Company | Common and Preferred Stock 900 shares | 112,041 | ||||||||
Truist Financial Corporation | Common and Preferred Stock 1,850 shares | 104,192 | ||||||||
Schlumberger Limited | Common and Preferred Stock 2,450 shares | 98,490 | ||||||||
Credit Acceptance Corporation | Common and Preferred Stock 191 shares | 84,485 | ||||||||
Celanese Corporation | Common and Preferred Stock 650 shares | 80,028 | ||||||||
Halliburton Company | Common and Preferred Stock 3,100 shares | 75,857 | ||||||||
Molson Coors Brewing Company Class B | Common and Preferred Stock 1,400 shares | 75,460 | ||||||||
Gilead Sciences Inc. | Common and Preferred Stock 1,150 shares | 74,727 | ||||||||
Dell Technologies Inc. Class C | Common and Preferred Stock 1,450 shares | 74,516 | ||||||||
Eli Lilly & Company | Common and Preferred Stock 550 shares | 72,287 | ||||||||
Juniper Networks, Inc. | Common and Preferred Stock 2,900 shares | 71,427 | ||||||||
Apache Corporation | Common and Preferred Stock 2,700 shares | 69,093 | ||||||||
Cognizant Technology Solutions Corporation Class A | Common and Preferred Stock 1,100 shares | 68,222 | ||||||||
Dish Network Corporation Class A | Common and Preferred Stock 1,900 shares | 67,393 | ||||||||
Hess Corporation LLC | Common and Preferred Stock 1,000 shares | 66,810 | ||||||||
Concho Resources Inc. | Common and Preferred Stock 750 shares | 65,678 | ||||||||
Cisco Systems Inc. | Common and Preferred Stock 1,300 shares | 62,348 | ||||||||
Fox Corporation Class A | Common and Preferred Stock 1,550 shares | 57,459 | ||||||||
Medtronic PLC | Common and Preferred Stock 400 shares | 45,380 | ||||||||
Alnylam Pharmaceuticals, Inc. | Common and Preferred Stock 350 shares | 40,310 | ||||||||
State Street Corporation | Common and Preferred Stock 500 shares | 39,550 | ||||||||
Mattel Inc. | Common and Preferred Stock 2,500 shares | 33,875 | ||||||||
Maxim Integrated Products Inc. | Common and Preferred Stock 550 shares | 33,831 | ||||||||
Biomarin Pharmaceutical Inc. | Common and Preferred Stock 400 shares | 33,820 | ||||||||
The Gap Inc. | Common and Preferred Stock 1,700 shares | 30,056 | ||||||||
Fox Corporation Class B | Common and Preferred Stock 766 shares | 27,882 | ||||||||
Micro Focus International PLC | Common and Preferred Stock 1,981 shares | 27,793 | ||||||||
Brighthouse Financial Inc. | Common and Preferred Stock 700 shares | 27,461 | ||||||||
Sprint Corporation | Common and Preferred Stock 5,024 shares | 26,175 | ||||||||
Qurate Retail Inc. | Common and Preferred Stock 3,100 shares | 26,133 | ||||||||
Aegon N.V. | Common and Preferred Stock 5,700 shares | 25,821 | ||||||||
Harley/Davidson Motor Company | Common and Preferred Stock 550 shares | 20,455 | ||||||||
Incyte Corporation | Common and Preferred Stock 200 shares | 17,464 | ||||||||
News Corporation Class A | Common and Preferred Stock 700 shares | 9,898 | ||||||||
Total Large Cap Value Asset Class | 16,618,292 | |||||||||
Participant Self-Directed Accounts | Various Investments | 2,591,327 | ||||||||
2,591,327 | ||||||||||
Real Estate Index Asset Class: | ||||||||||
Vanguard Real Estate Index Fund Institutional Shares | Mutual Fund 578,321 units | 11,780,405 | ||||||||
14
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
NT Collective Global Real Estate Index Fund - Non Lending* | Collective Trust Fund 4,931 units | 1,165,380 | ||||||||
Total Real Estate Index Asset Class | 12,945,785 | |||||||||
Small-Mid Cap Growth Asset Class: | ||||||||||
Northern Trust Global Investment Russell 2000 Growth Index Fund - Non Lending* | Collective Trust Fund 935 units | 373,754 | ||||||||
Interest Bearing Cash | Cash and Cash Equivalents 352,866 units | 352,866 | ||||||||
Clean Harbors Inc. | Common and Preferred Stock 2,523 shares | 216,347 | ||||||||
Dexcom Inc. | Common and Preferred Stock 796 shares | 174,117 | ||||||||
Logmein Inc. | Common and Preferred Stock 1,847 shares | 158,362 | ||||||||
RingCentral, Inc. Class A | Common and Preferred Stock 905 shares | 152,646 | ||||||||
On Semiconductor Corporation | Common and Preferred Stock 5,689 shares | 138,698 | ||||||||
Hanesbrands Inc. | Common and Preferred Stock 8,078 shares | 119,958 | ||||||||
Sally Beauty Holdings Inc. | Common and Preferred Stock 6,454 shares | 117,786 | ||||||||
Inspire Medical Systems Inc. | Common and Preferred Stock 1,564 shares | 116,064 | ||||||||
Skechers USA Inc. Class A | Common and Preferred Stock 2,685 shares | 115,965 | ||||||||
SBV Financial Group | Common and Preferred Stock 450 shares | 112,968 | ||||||||
Crown Holdings Inc. | Common and Preferred Stock 1,543 shares | 111,929 | ||||||||
Burlington Stores Inc. | Common and Preferred Stock 458 shares | 104,438 | ||||||||
Sensata Technologies BV Holding | Common and Preferred Stock 1,936 shares | 104,292 | ||||||||
J2 Global Inc. | Common and Preferred Stock 1,096 shares | 102,706 | ||||||||
Keysight Technologies Inc. | Common and Preferred Stock 990 shares | 101,604 | ||||||||
Exact Sciences Corporation | Common and Preferred Stock 1,057 shares | 97,751 | ||||||||
CONMED Corporation | Common and Preferred Stock 851 shares | 95,167 | ||||||||
Masco Corporation | Common and Preferred Stock 1,966 shares | 94,348 | ||||||||
Q2 Holdings Inc. | Common and Preferred Stock 1,150 shares | 93,242 | ||||||||
Kansas City Southern | Common and Preferred Stock 607 shares | 92,968 | ||||||||
Trinet Group Inc. | Common and Preferred Stock 1,610 shares | 91,142 | ||||||||
Tandem Diabetes Care Inc. | Common and Preferred Stock 1,497 shares | 89,236 | ||||||||
Five9 Inc. | Common and Preferred Stock 1,289 shares | 84,533 | ||||||||
Pinnacle Financial Partners | Common and Preferred Stock 1,304 shares | 83,456 | ||||||||
Rapid7 Inc. | Common and Preferred Stock 1,488 shares | 83,358 | ||||||||
TransUnion | Common and Preferred Stock 965 shares | 82,614 | ||||||||
Horizon Therapeutics PLC | Common and Preferred Stock 2,276 shares | 82,391 | ||||||||
STERIS plc | Common and Preferred Stock 535 shares | 81,545 | ||||||||
CarMax Inc. | Common and Preferred Stock 930 shares | 81,533 | ||||||||
AAR Corporation | Common and Preferred Stock 1,736 shares | 78,294 | ||||||||
Cinemark Holdings Inc. | Common and Preferred Stock 2,295 shares | 77,686 | ||||||||
ABM Industrials Inc. | Common and Preferred Stock 2,056 shares | 77,532 | ||||||||
SS&C Technologies Holdings Inc. | Common and Preferred Stock 1,245 shares | 76,443 | ||||||||
Nuance Communications Inc. | Common and Preferred Stock 4,243 shares | 75,653 | ||||||||
Solarwinds Corporation | Common and Preferred Stock 4,077 shares | 75,628 | ||||||||
Mednax Inc. | Common and Preferred Stock 2,718 shares | 75,533 | ||||||||
Everbridge Inc. | Common and Preferred Stock 925 shares | 72,224 | ||||||||
Tyler Technologies Inc. | Common and Preferred Stock 240 shares | 72,005 | ||||||||
Ritchie Bros Auctioneers Inc. | Common and Preferred Stock 1,664 shares | 71,469 | ||||||||
15
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Biotelemetry Inc. | Common and Preferred Stock 1,534 shares | 71,024 | ||||||||
Belden Inc. | Common and Preferred Stock 1,279 shares | 70,345 | ||||||||
Insulet Corporation | Common and Preferred Stock 409 shares | 70,021 | ||||||||
Polaris Inc. | Common and Preferred Stock 685 shares | 69,665 | ||||||||
John Bean Technologies Corporation | Common and Preferred Stock 608 shares | 68,497 | ||||||||
Anaplan Inc. | Common and Preferred Stock 1,261 shares | 66,076 | ||||||||
Tennant Company | Common and Preferred Stock 826 shares | 64,362 | ||||||||
Chewy Inc. Class A | Common and Preferred Stock 2,169 shares | 62,901 | ||||||||
Middleby Corporation | Common and Preferred Stock 573 shares | 62,755 | ||||||||
Cimpress plc | Common and Preferred Stock 497 shares | 62,508 | ||||||||
Viavi Solutions Inc. NPV | Common and Preferred Stock 4,144 shares | 62,160 | ||||||||
Natera Inc. | Common and Preferred Stock 1,814 shares | 61,114 | ||||||||
Carter Inc. | Common and Preferred Stock 546 shares | 59,700 | ||||||||
Merit Medical Systems Inc. | Common and Preferred Stock 1,877 shares | 58,600 | ||||||||
Owens Corning | Common and Preferred Stock 889 shares | 57,892 | ||||||||
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending* | Collective Trust Fund 57,848 units | 57,848 | ||||||||
Zebra Technologies Corporation | Common and Preferred Stock 220 shares | 56,197 | ||||||||
Amedisys Inc. | Common and Preferred Stock 335 shares | 55,918 | ||||||||
Kirby Corporation | Common and Preferred Stock 622 shares | 55,688 | ||||||||
Cornerstone OnDemand Inc. | Common and Preferred Stock 951 shares | 55,681 | ||||||||
Lattice Semiconductor Company | Common and Preferred Stock 2,879 shares | 55,104 | ||||||||
Frontdoor Inc. | Common and Preferred Stock 1,162 shares | 55,102 | ||||||||
Syneos Health Inc. | Common and Preferred Stock 926 shares | 55,074 | ||||||||
2U Inc. | Common and Preferred Stock 2,237 shares | 53,666 | ||||||||
Inphi Corporation | Common and Preferred Stock 715 shares | 52,924 | ||||||||
Papa Johns International Inc. | Common and Preferred Stock 828 shares | 52,288 | ||||||||
Shutterstock Inc. | Common and Preferred Stock 1,174 shares | 50,341 | ||||||||
Heartland Express Inc. | Common and Preferred Stock 2,309 shares | 48,604 | ||||||||
LHC Group Inc. | Common and Preferred Stock 352 shares | 48,492 | ||||||||
Penumbra Inc. | Common and Preferred Stock 291 shares | 47,803 | ||||||||
Ambarella Inc. Shares | Common and Preferred Stock 775 shares | 46,934 | ||||||||
Axogen Inc. | Common and Preferred Stock 2,585 shares | 46,246 | ||||||||
Crocs Inc. | Common and Preferred Stock 1,097 shares | 45,953 | ||||||||
Lululemon Athletica Inc. | Common and Preferred Stock 198 shares | 45,871 | ||||||||
Chegg Inc. | Common and Preferred Stock 1,205 shares | 45,682 | ||||||||
Haemonetics Corporation | Common and Preferred Stock 397 shares | 45,615 | ||||||||
Grand Canyon Education Inc. | Common and Preferred Stock 464 shares | 44,447 | ||||||||
Woodward Inc. | Common and Preferred Stock 369 shares | 43,704 | ||||||||
C.H. Robinson Worldwide Inc. | Common and Preferred Stock 555 shares | 43,401 | ||||||||
Tetra Tech Inc. | Common and Preferred Stock 500 shares | 43,080 | ||||||||
Trimble Inc. | Common and Preferred Stock 1,027 shares | 42,816 | ||||||||
Sea Limited | Common and Preferred Stock 1,060 shares | 42,633 | ||||||||
Nordson Corporation | Common and Preferred Stock 255 shares | 41,524 | ||||||||
Fireeye Inc. | Common and Preferred Stock 2,465 shares | 40,746 | ||||||||
Gartner Inc. | Common and Preferred Stock 254 shares | 39,141 | ||||||||
16
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Integra Lifesciences Holding Corporation | Common and Preferred Stock 669 shares | 38,989 | ||||||||
Teradyne Inc. | Common and Preferred Stock 549 shares | 37,436 | ||||||||
Quidel Corporation | Common and Preferred Stock 496 shares | 37,215 | ||||||||
Switch Inc. Class A | Common and Preferred Stock 2,472 shares | 36,635 | ||||||||
Roku Inc. Class A | Common and Preferred Stock 269 shares | 36,019 | ||||||||
Deciphera Pharmaceuticals Inc. | Common and Preferred Stock 575 shares | 35,788 | ||||||||
Matson Inc. | Common and Preferred Stock 871 shares | 35,537 | ||||||||
Hamilton Lane Inc. Class A | Common and Preferred Stock 584 shares | 34,806 | ||||||||
Forward Air Corporation | Common and Preferred Stock 496 shares | 34,695 | ||||||||
Wolverine World Wide Inc. | Common and Preferred Stock 1,022 shares | 34,482 | ||||||||
Under Armour Inc. Class C | Common and Preferred Stock 1,783 shares | 34,198 | ||||||||
Immunomedics Inc. | Common and Preferred Stock 1,614 shares | 34,152 | ||||||||
Revance Therapeutics Inc. | Common and Preferred Stock 2,066 shares | 33,531 | ||||||||
Wisdomtree Investments Inc. | Common and Preferred Stock 6,854 shares | 33,173 | ||||||||
Graphic Packaging Holding Company | Common and Preferred Stock 1,984 shares | 33,034 | ||||||||
NIC Inc. | Common and Preferred Stock 1,475 shares | 32,966 | ||||||||
Pinterest Inc. Class A | Common and Preferred Stock 1,766 shares | 32,918 | ||||||||
Reata Pharmaceuticals Inc. Class A | Common and Preferred Stock 161 shares | 32,913 | ||||||||
LPL Financial Holdings Inc. | Common and Preferred Stock 356 shares | 32,841 | ||||||||
Boot Barn Holdings Inc. | Common and Preferred Stock 725 shares | 32,284 | ||||||||
National Cinemedia Inc. | Common and Preferred Stock 4,345 shares | 31,675 | ||||||||
Heron Therapeutics Inc. | Common and Preferred Stock 1,318 shares | 30,973 | ||||||||
Prestige Consumer Healthcare Inc. | Common and Preferred Stock 752 shares | 30,456 | ||||||||
Freshpet Inc. | Common and Preferred Stock 507 shares | 29,959 | ||||||||
Napco Security Technologies Inc. | Common and Preferred Stock 1,000 shares | 29,390 | ||||||||
New Relic Inc. | Common and Preferred Stock 438 shares | 28,781 | ||||||||
Kodiak Sciences Inc. | Common and Preferred Stock 397 shares | 28,564 | ||||||||
Floor & Decor Holdings Inc. | Common and Preferred Stock 557 shares | 28,301 | ||||||||
Agios Pharmaceuticals Inc. | Common and Preferred Stock 592 shares | 28,268 | ||||||||
Nevro Corporation | Common and Preferred Stock 236 shares | 27,739 | ||||||||
MSC Industrial Direct Inc. Class A | Common and Preferred Stock 353 shares | 27,700 | ||||||||
Abiomed Inc. | Common and Preferred Stock 155 shares | 26,441 | ||||||||
Proofpoint Inc. | Common and Preferred Stock 230 shares | 26,399 | ||||||||
Wabtec Corporation | Common and Preferred Stock 338 shares | 26,296 | ||||||||
Viking Therapeutics Inc. | Common and Preferred Stock 3,263 shares | 26,169 | ||||||||
Cooper Companies Inc. | Common and Preferred Stock 81 shares | 26,024 | ||||||||
Pluralsight Inc. Class A | Common and Preferred Stock 1,487 shares | 25,591 | ||||||||
Manhattan Associates, Inc. | Common and Preferred Stock 312 shares | 24,882 | ||||||||
Neurocrine Biosciences Inc. | Common and Preferred Stock 225 shares | 24,185 | ||||||||
Proto Labs Inc. | Common and Preferred Stock 238 shares | 24,169 | ||||||||
Performance Food Group Company | Common and Preferred Stock 463 shares | 23,835 | ||||||||
CarGurus Inc. Class A | Common and Preferred Stock 663 shares | 23,324 | ||||||||
Mirati Therapeutics Inc. | Common and Preferred Stock 179 shares | 23,066 | ||||||||
Paysoftware Inc. | Common and Preferred Stock 87 shares | 23,034 | ||||||||
Bank Ozk | Common and Preferred Stock 754 shares | 23,001 | ||||||||
Sage Therapeutics Inc. | Common and Preferred Stock 306 shares | 22,090 | ||||||||
Kennametal Inc. | Common and Preferred Stock 594 shares | 21,913 | ||||||||
17
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Euronet Worldwide Inc. | Common and Preferred Stock 137 shares | 21,586 | ||||||||
Costar Group Inc. | Common and Preferred Stock 36 shares | 21,539 | ||||||||
FTI Consulting Inc. | Common and Preferred Stock 194 shares | 21,468 | ||||||||
Five Below, Inc. | Common and Preferred Stock 167 shares | 21,353 | ||||||||
Docusign Inc. | Common and Preferred Stock 284 shares | 21,047 | ||||||||
Masimo Corporation | Common and Preferred Stock 132 shares | 20,864 | ||||||||
Universal Display Corporation | Common and Preferred Stock 100 shares | 20,607 | ||||||||
Summit Materials Inc. Class A | Common and Preferred Stock 849 shares | 20,291 | ||||||||
Crispr Therapeutics AG | Common and Preferred Stock 318 shares | 19,368 | ||||||||
Constellium SE Class A | Common and Preferred Stock 1,428 shares | 19,135 | ||||||||
Zynga Inc. | Common and Preferred Stock 3,099 shares | 18,966 | ||||||||
Cryoport Inc. | Common and Preferred Stock 1,152 shares | 18,962 | ||||||||
MKS Instruments | Common and Preferred Stock 171 shares | 18,812 | ||||||||
Okta Inc. Class A | Common and Preferred Stock 162 shares | 18,690 | ||||||||
DBV Technologies | Common and Preferred Stock 1,596 shares | 17,077 | ||||||||
RealPage Inc. | Common and Preferred Stock 316 shares | 16,985 | ||||||||
Fox Factory Holding Corporation | Common and Preferred Stock 235 shares | 16,349 | ||||||||
Arrowhead Pharmaceuticals Inc. | Common and Preferred Stock 180 shares | 11,417 | ||||||||
SmileDirectClub Inc. Class A | Common and Preferred Stock 1,044 shares | 9,125 | ||||||||
Acadia Pharmaceuticals Inc. | Common and Preferred Stock 205 shares | 8,770 | ||||||||
Rignet Inc. | Common and Preferred Stock 1,180 shares | 7,788 | ||||||||
Cerence Inc. | Common and Preferred Stock 289 shares | 6,540 | ||||||||
Endologix Inc. | Common and Preferred Stock 2,370 shares | 3,745 | ||||||||
Spectrum Pharmaceuticals Inc. | Common and Preferred Stock 904 shares | 3,291 | ||||||||
Total Small-Mid Cap Growth Asset Class | 8,876,006 | |||||||||
Small-Mid Cap Index Asset Class: | ||||||||||
NT Collective Extended Equity Market Index Fund / Non Lending* | Collective Trust Fund 148,326 units | 32,772,597 | ||||||||
Total Small-Mid Cap Index Asset Class | 32,772,597 | |||||||||
Small-Mid Cap Value Asset Class: | ||||||||||
Northern Trust Global Investment Russell 2000 Value Index Fund - Non Lending* | Collective Trust Fund 5,422 units | 1,793,404 | ||||||||
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending* | Collective Trust Fund 775,385 units | 775,385 | ||||||||
Western Alliance Bancorporation | Common and Preferred Stock 10,541 shares | 600,837 | ||||||||
Entegris Inc. | Common and Preferred Stock 11,552 shares | 578,640 | ||||||||
Waste Connections Inc. | Common and Preferred Stock 4,895 shares | 444,417 | ||||||||
Interest Bearing Cash | Cash and Cash Equivalents 441,470 units | 441,470 | ||||||||
Citigroup Inc. | Common and Preferred Stock 5,985 shares | 433,896 | ||||||||
FMC Corporation | Common and Preferred Stock 4,088 shares | 408,064 | ||||||||
Citizens Financial Group, Inc. | Common and Preferred Stock 9,900 shares | 402,039 | ||||||||
Clean Harbors Inc. | Common and Preferred Stock 4,624 shares | 396,508 | ||||||||
KAR Auction Services Inc. | Common and Preferred Stock 17,716 shares | 386,032 | ||||||||
Kosmos Energy Limited | Common and Preferred Stock 67,020 shares | 382,014 | ||||||||
Woodward Inc. | Common and Preferred Stock 3,148 shares | 372,849 | ||||||||
18
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
First Horizon National Corporation | Common and Preferred Stock 4,300 shares | 358,822 | ||||||||
Popular, Inc.* | Common and Preferred Stock 6,100 shares | 358,375 | ||||||||
RPT Realty | Common and Preferred Stock 23,740 shares | 357,050 | ||||||||
Ameris Bancorp | Common and Preferred Stock 8,284 shares | 352,401 | ||||||||
IAA Spinco Inc. | Common and Preferred Stock 7,403 shares | 348,385 | ||||||||
Ametek Inc. | Common and Preferred Stock 3,476 shares | 346,696 | ||||||||
Amphenol Corporation Class A | Common and Preferred Stock 3,076 shares | 332,915 | ||||||||
Synopsys Inc. | Common and Preferred Stock 2,383 shares | 331,714 | ||||||||
Cairn Energy PLC | Common and Preferred Stock 60,700 shares | 329,692 | ||||||||
Bio-Rad Laboratories, Inc. Class A | Common and Preferred Stock 874 shares | 323,406 | ||||||||
Axis Capital Holdings Limited | Common and Preferred Stock 5,435 shares | 323,056 | ||||||||
Goodyear Tire & Rubber Company | Common and Preferred Stock 20,500 shares | 318,878 | ||||||||
Mellanox Technologies Limited | Common and Preferred Stock 2,683 shares | 314,394 | ||||||||
CNO Financial Group, Inc. | Common and Preferred Stock 17,000 shares | 308,210 | ||||||||
The Bank of N.T. Butterfield & Son Limited | Common and Preferred Stock 8,159 shares | 302,046 | ||||||||
UGI Corporation | Common and Preferred Stock 6,599 shares | 298,011 | ||||||||
RenaissanceRe Holdings Limited | Common and Preferred Stock 1,497 shares | 293,442 | ||||||||
BWX Technologies Inc. | Common and Preferred Stock 4,593 shares | 285,133 | ||||||||
BorgWarner Inc. | Common and Preferred Stock 6,488 shares | 281,449 | ||||||||
Embraer SA | Common and Preferred Stock 14,400 shares | 280,656 | ||||||||
Helen Trustoy Limited | Common and Preferred Stock 1,479 shares | 265,909 | ||||||||
Knight-Swift Transportation Holdings Inc. | Common and Preferred Stock 7,364 shares | 263,926 | ||||||||
Office Depot, Inc. | Common and Preferred Stock 95,600 shares | 261,944 | ||||||||
EnerSys Inc | Common and Preferred Stock 3,483 shares | 260,633 | ||||||||
Royal Mail PLC | Common and Preferred Stock 43,100 shares | 256,661 | ||||||||
LKQ Corporation | Common and Preferred Stock 7,149 shares | 255,219 | ||||||||
Reliance Steel & Aluminum Company | Common and Preferred Stock 2,073 shares | 248,262 | ||||||||
Hewlett Packard Enterprise Company | Common and Preferred Stock 15,500 shares | 245,830 | ||||||||
TCF Financial Corporation | Common and Preferred Stock 5,252 shares | 245,794 | ||||||||
Amerco | Common and Preferred Stock 640 shares | 240,525 | ||||||||
Taylor Morrison Home Corporation | Common and Preferred Stock 10,836 shares | 236,875 | ||||||||
Ingredion Inc. | Common and Preferred Stock 2,530 shares | 235,164 | ||||||||
Discovery Communications, Inc. Series C | Common and Preferred Stock 7,700 shares | 234,773 | ||||||||
Dollar Tree Inc. | Common and Preferred Stock 2,464 shares | 231,739 | ||||||||
Halozyme Therapeutics Inc. | Common and Preferred Stock 13,006 shares | 230,596 | ||||||||
Apache Corporation | Common and Preferred Stock 9,000 shares | 230,310 | ||||||||
Quanta Services Inc. | Common and Preferred Stock 5,650 shares | 230,012 | ||||||||
BMC Holdings Inc. | Common and Preferred Stock 7,786 shares | 223,380 | ||||||||
Nvent Electric PLC | Common and Preferred Stock 8,726 shares | 223,211 | ||||||||
Brandywine Realty Trust | Common and Preferred Stock 14,108 shares | 222,201 | ||||||||
Henry Schein Inc. | Common and Preferred Stock 3,215 shares | 214,505 | ||||||||
Equitrans Midstream Corporation NPV | Common and Preferred Stock 3,500 shares | 212,224 | ||||||||
Charles River Laboratories International Inc. | Common and Preferred Stock 1,387 shares | 211,878 | ||||||||
Catalent Inc. | Common and Preferred Stock 3,748 shares | 211,012 | ||||||||
Heico Corporation Class A | Common and Preferred Stock 2,313 shares | 207,083 | ||||||||
Vistra Energy Corporation | Common and Preferred Stock 9,000 shares | 206,910 | ||||||||
Corning Inc. | Common and Preferred Stock 7,000 shares | 203,770 | ||||||||
19
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Magna International Inc. | Common and Preferred Stock 3,700 shares | 202,908 | ||||||||
Jacobs Engineering Group Inc. | Common and Preferred Stock 2,200 shares | 197,626 | ||||||||
Copart Inc. | Common and Preferred Stock 2,161 shares | 196,521 | ||||||||
STERIS plc | Common and Preferred Stock 1,289 shares | 196,469 | ||||||||
Hexcel Corporation | Common and Preferred Stock 2,672 shares | 195,884 | ||||||||
Coherent Inc. | Common and Preferred Stock 1,173 shares | 195,129 | ||||||||
Arrow Electric Inc. | Common and Preferred Stock 2,300 shares | 194,902 | ||||||||
Pacwest Bancorp Company | Common and Preferred Stock 5,003 shares | 191,465 | ||||||||
NRG Energy Inc. | Common and Preferred Stock 4,800 shares | 190,800 | ||||||||
Fluor Corporation | Common and Preferred Stock 10,100 shares | 190,688 | ||||||||
Nextier Oilfield Solutions Inc. | Common and Preferred Stock 28,291 shares | 189,550 | ||||||||
Keysight Technologies Inc. | Common and Preferred Stock 1,841 shares | 188,942 | ||||||||
Bed Bath & Beyond Inc. | Common and Preferred Stock 10,800 shares | 186,840 | ||||||||
AXA Equitable Holdings, Inc. | Common and Preferred Stock 7,500 shares | 185,850 | ||||||||
Centene Corporation | Common and Preferred Stock 2,900 shares | 182,323 | ||||||||
Cboe Global Markets Inc. | Common and Preferred Stock 1,517 shares | 182,040 | ||||||||
Bunge Limited | Common and Preferred Stock 3,100 shares | 178,405 | ||||||||
Teradata Corporation | Common and Preferred Stock 6,463 shares | 173,015 | ||||||||
Cabot Corporation | Common and Preferred Stock 3,490 shares | 165,845 | ||||||||
Mid-American Apartment Communities Inc. | Common and Preferred Stock 1,256 shares | 165,616 | ||||||||
CNH Industrial NV | Common and Preferred Stock 15,000 shares | 165,000 | ||||||||
Graco Inc. | Common and Preferred Stock 3,130 shares | 162,760 | ||||||||
Navistar International Corporation | Common and Preferred Stock 5,600 shares | 162,064 | ||||||||
Adient PLC | Common and Preferred Stock 7,500 shares | 159,375 | ||||||||
Qorvo, Inc. | Common and Preferred Stock 1,352 shares | 157,143 | ||||||||
STAG Industrial Inc. | Common and Preferred Stock 4,886 shares | 154,251 | ||||||||
Huntsman Corporation | Common and Preferred Stock 6,358 shares | 153,609 | ||||||||
Reinsurance Group of America Inc. | Common and Preferred Stock 931 shares | 151,809 | ||||||||
IDEX Corporation | Common and Preferred Stock 878 shares | 151,016 | ||||||||
Tri Pointe Homes, Inc. | Common and Preferred Stock 9,600 shares | 149,568 | ||||||||
Advance Auto Parts Inc. | Common and Preferred Stock 930 shares | 148,949 | ||||||||
Healthcare Realty Trust | Common and Preferred Stock 4,442 shares | 148,230 | ||||||||
ViaSat, Inc. | Common and Preferred Stock 2,020 shares | 147,854 | ||||||||
News Corporation Class A | Common and Preferred Stock 10,400 shares | 147,056 | ||||||||
PPL Corporation | Common and Preferred Stock 4,000 shares | 143,520 | ||||||||
LivaNova PLC | Common and Preferred Stock 1,902 shares | 143,468 | ||||||||
Parsley Energy Inc. Class A | Common and Preferred Stock 7,523 shares | 142,260 | ||||||||
Enstar Group Ltd. | Common and Preferred Stock 670 shares | 138,596 | ||||||||
Astronics Corporation | Common and Preferred Stock 4,934 shares | 137,905 | ||||||||
Servicemaster Global Holdings Inc. | Common and Preferred Stock 3,558 shares | 137,552 | ||||||||
Prosperity Bancshares Inc. | Common and Preferred Stock 1,879 shares | 135,081 | ||||||||
Whiting Petroleum Corporation | Common and Preferred Stock 17,825 shares | 130,836 | ||||||||
Old Republic International Corporation | Common and Preferred Stock 5,842 shares | 130,686 | ||||||||
Mscope Holding Company Inc. | Common and Preferred Stock 8,800 shares | 124,872 | ||||||||
Federal Signal Corporation | Common and Preferred Stock 3,690 shares | 119,003 | ||||||||
Materion Corporation | Common and Preferred Stock 1,967 shares | 116,938 | ||||||||
EQT Corporation | Common and Preferred Stock 10,466 shares | 114,079 | ||||||||
20
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
Potlatchdeltic Corporation | Common and Preferred Stock 2,568 shares | 111,117 | ||||||||
Fabrinet | Common and Preferred Stock 1,702 shares | 110,358 | ||||||||
Discover Financial Services | Common and Preferred Stock 1,300 shares | 110,266 | ||||||||
Kennametal Inc. | Common and Preferred Stock 2,970 shares | 109,563 | ||||||||
Deckers Outdoor Corporation | Common and Preferred Stock 637 shares | 107,564 | ||||||||
Teradyne Inc. | Common and Preferred Stock 1,547 shares | 105,490 | ||||||||
Markel Corporation Holding Company | Common and Preferred Stock 92 shares | 105,172 | ||||||||
American Eagle Outfitters Inc. | Common and Preferred Stock 6,795 shares | 99,887 | ||||||||
Innospec Inc. | Common and Preferred Stock 950 shares | 98,268 | ||||||||
Avnet Inc. | Common and Preferred Stock 2,300 shares | 97,612 | ||||||||
Albany International Corporation Class A | Common and Preferred Stock 1,267 shares | 96,191 | ||||||||
TD Ameritrade Holding Corporation | Common and Preferred Stock 1,912 shares | 95,026 | ||||||||
Texas Capital Bancshares Inc. | Common and Preferred Stock 1,666 shares | 94,579 | ||||||||
Sallie Mae Corporation | Common and Preferred Stock 10,600 shares | 94,446 | ||||||||
Cypress Semiconductor Corporation | Common and Preferred Stock 3,961 shares | 92,410 | ||||||||
Bio-Techne Corporation | Common and Preferred Stock 419 shares | 91,975 | ||||||||
PPDC Energy Inc. | Common and Preferred Stock 3,475 shares | 90,941 | ||||||||
Apogee Enterprises, Inc. | Common and Preferred Stock 2,758 shares | 89,635 | ||||||||
Fifth Third Bancorp | Common and Preferred Stock 2,400 shares | 73,776 | ||||||||
Interpublic Group Companies Inc. | Common and Preferred Stock 3,100 shares | 71,610 | ||||||||
State Street Corporation | Common and Preferred Stock 900 shares | 71,190 | ||||||||
Colony Capital Inc. Class A | Common and Preferred Stock 14,800 units | 70,300 | ||||||||
Ericsson, Inc. | Common and Preferred Stock 8,000 shares | 70,240 | ||||||||
Euronet Worldwide Inc. | Common and Preferred Stock 444 shares | 69,957 | ||||||||
Avis Budget Group Inc. | Common and Preferred Stock 2,100 shares | 67,704 | ||||||||
Evercore Inc. | Common and Preferred Stock 900 shares | 67,284 | ||||||||
Viacom CBS Inc. NPV | Common and Preferred Stock 1,600 shares | 67,152 | ||||||||
Zimmer Biomet Holdings Inc | Common and Preferred Stock 400 shares | 59,872 | ||||||||
JetBlue Airways Corporation | Common and Preferred Stock 3,000 shares | 56,160 | ||||||||
Franks International NV | Common and Preferred Stock 10,500 shares | 54,285 | ||||||||
The Geo Group, Inc. | Common and Preferred Stock 3,250 shares | 53,983 | ||||||||
Halliburton Company | Common and Preferred Stock 2,200 shares | 53,834 | ||||||||
National Oilwell Varco, Inc. | Common and Preferred Stock 2,100 shares | 52,605 | ||||||||
Harley/Davidson Motor Company | Common and Preferred Stock 1,400 shares | 52,066 | ||||||||
Lazard Limited Class A | Common and Preferred Stock 1,300 shares | 51,948 | ||||||||
Cenovus Energy Inc. | Common and Preferred Stock 5,100 shares | 51,765 | ||||||||
Murphy Oil Corporation | Common and Preferred Stock 1,900 shares | 50,920 | ||||||||
Livent Corporation | Common and Preferred Stock 5,742 shares | 49,094 | ||||||||
Alleghany Corporation | Common and Preferred Stock 60 shares | 47,974 | ||||||||
Stealthgas Inc. | Common and Preferred Stock 13,470 shares | 46,202 | ||||||||
Boise Cascade Company | Common and Preferred Stock 1,049 shares | 38,320 | ||||||||
Keycorp | Common and Preferred Stock 1,600 shares | 32,384 | ||||||||
Hess Corporation LLC | Common and Preferred Stock 400 shares | 26,724 | ||||||||
Superior Energy Services Inc. | Common and Preferred Stock 2,370 shares | 11,874 | ||||||||
Total Small-Mid Cap Value Asset Class | 31,014,653 | |||||||||
Notes Receivable from Participants* | Interest Rate 4.25% - 9.25% | 15,387,570 | ||||||||
21
Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)
Identity of Issue | Description of Investment | Current Value | ||||||||
15,387,570 | ||||||||||
Other | ||||||||||
ML Sweep Account | Cash and Cash Equivalents 24,938 units | 24,938 | ||||||||
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending* | Collective Trust Fund 8,482 units | 8,482 | ||||||||
33,420 | ||||||||||
Grand Total | $ | 542,649,268 | ||||||||
* Indicates party-in-interest | ||||
22
THE RETIREMENT AND SAVINGS PLAN FOR
AMGEN MANUFACTURING, LIMITED
INDEX TO EXHIBIT
23
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
The Retirement and Savings Plan for Amgen Manufacturing, Limited (Name of Plan) | ||||||
Date: | June 16, 2020 | By: | /s/ PETER H. GRIFFITH | |||
Peter H. Griffith | ||||||
Deputy Chairman and Chief Financial Officer | ||||||
Amgen Manufacturing, Limited | ||||||
24
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 33-47605, 333-144580 and 333-216715) pertaining to The Retirement and Savings Plan for Amgen Manufacturing, Limited of Amgen Inc. of our report dated June 16, 2020, with respect to the financial statements and schedule of The Retirement and Savings Plan for Amgen Manufacturing, Limited included in this Annual Report (Form 11-K) for the year ended December 31, 2019.
/s/ ERNST & YOUNG LLP
Los Angeles, California
June 16, 2020